Litigation Notes provides independent investment research on corporate legal matters to hedge funds and institutional investors. Mr. Crary, an expert in patent litigation, has over 30 years of experience analyzing lawsuits for investors. The service covers a range of sectors with a focus on pharmaceuticals, major drugs, health care, biotechnology, high technology, and tobacco. To learn more about the content of Litigation Notes, please contact us. The following is a list of recent reports.
December, 2004
Research In Motion Federal Circuit Decision
Pfizer v. Ranbaxy Laboratories Lipitor Case
November, 2004
Johnson & Johnson v. Mylan Oxybutynin Case
Purdue Pharma v. Endo Pharmaceuticals
Merck Vioxx Litigation
October, 2004
Amgen v. Transkaryotic Therapies
Marsh & McLennan Bid Rigging Case
Star Scientific v. R.J. Reynolds Tobacco
Merck's Vioxx Litigation
September, 2004
Cambridge Antibody Technology v. Abbott Labs
Johnson & Johnson/Mylan Levaquin Case
GlaxoSmithKline Ondansetron Litigation
August, 2004
Mylan's District Court Fentanyl Patch Decision
Mylan Labs Fentanyl Patch Litigation
Affymetrix v. Illumina
July, 2004
Ariad Patent Case Against Eli Lilly
FDA’s Bioquivalence Methodology Litigation
Wyeth's Fen-Phen Litigation Exposure
June, 2004
Mylan Laboratories Fentanyl Patch Case
Research in Motion Oral Argument in Patent Case
Teva's Accupril Case Against Pfizer
May, 2004
Cambridge Antibody Technology (CATG) Case Against Abbott Laboratories (ABT)
Eli Lilly (LLY) Zyprexa Litigation: Post-trial and supplemental briefs
Georgia-Pacific (GP) Asbestos Litigation
Rambus (RMBS) antitrust case against Micron (MU), Infineon (IFX) and Hynix Semiconductor (HXSEY.PK)
April, 2004
SCO's Linux Copyright Litigation
Bristol-Myers (BMY)/Sanofi-Synthelabo (SNY) Plavix Litigation
Eli Lilly (LLY) Zyprexa Case/Post-trial Update
Mylan Labs (MYL) Authorized Generics Case
March, 2004
Pfizer (PFE) Xalatan Patent Litigation
Research in Motion (RIMM) Patent Litigation
Rambus (RMBS) Antitrust Claim Against Micron (MU), Infineon (IFX) and Hynix (HXSEY.PK)
February, 2004
Eli Lilly (LLY) Zyprexa trial update and further thoughts
Kos Pharmaceuticals (KOSP) Niaspan Patent Litigation
Amgen (AMGN) v. Transkaryotic Therapies (TKTX): Ruling on doctrine of equivalents
January, 2004
Amgen (AMGN) v. Transkaryotic Therapies (TKTX): Post-trial Briefs
Orthodontic Centers of America Inc. (OCA)/Orthodontist Cases
Martha Stewart Obstruction of Justice Case (MSO)
Eli Lilly (LLY) Zyprexa Patent Case
Archive: 2003, 2004, 2005, 2006
© 2006 Calvert D. Crary, Litigation Notes: Independent Investment Research